Evaluation of an Effective Intradermal Foot-and-Mouth Disease Vaccine for Early Protection
Vaccines · 13.03.2026 · 14 (3) · 263
DOI: 10.3390/vaccines14030263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 13.03.2026. Verfasst von Dong-Wan Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, 177, Hyeoksin 8-ro, Gimcheon-si 39660, Gyeongsangbuk-do, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Animal and Plant Quarantine Agency, National Animal Disease Research Project of the Animal and Plant Quarantine Agency, Gimcheon-si, Gyeongsangbuk-do, Republic of Korea.
Abstract (Originalsprache)
Background
In South Korea, foot-and-mouth disease (FMD), a highly contagious viral infection that affects cloven-hoofed animals, has led to the implementation of a bivalent FMD vaccination program. The current FMD vaccination strategy involves intramuscular (IM) administration to the shoulder region of the swine. However, this method is associated with adverse reactions at injection sites. Our previous studies have demonstrated that intradermal (ID) vaccination eliminates these side effects while maintaining immunogenicity comparable to that of IM vaccination. This study aimed to assess the early immune response induced by ID vaccination and compare its protective ability against FMDV serotype O with that of a commercial IM vaccine recently used in South Korea.
Methods
An ID FMD vaccine was evaluated using two adjuvants, ISA 207 (50%) and EMULSIGEN-D (15%). Virus neutralization (VN) titers and structural protein levels were measured to compare efficacy across groups. To assess the early protective efficacy of ID vaccination, viral challenge experiments were conducted at 7 and 14 days post-vaccination (dpv).
Results
Swine vaccinated via the ID route exhibited no clinical symptoms at 14 dpv, indicating effective early protection against FMD (O/AS/SKR/2019). In addition, no side effects of FMD ID vaccination were observed.
Conclusions
These results suggest that ID vaccination could serve as a viable alternative to conventional IM vaccination, which is frequently associated with adverse effects. Importantly, this study demonstrates that ID vaccination can provide effective early protection within 7–14 days post-vaccination, highlighting its potential utility for emergency outbreak control.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, 177, Hyeoksin 8-ro, Gimcheon-si 39660, Gyeongsangbuk-do, Republic of Korea.
ORCID-Profile: Hyejin Kim, Ji-Hyeon Hwang, Sun Young Park, Young-Joon Ko, Yoon-Hee Lee, Jong-Hyeon Park, Sung-Han Park
Förderung
- Animal and Plant Quarantine Agency
- National Animal Disease Research Project of the Animal and Plant Quarantine Agency, Gimcheon-si, Gyeongsangbuk-do, Republic of Korea
Zitieren
APA
Kim, D. W., Lee, S. Y., Kim, T. J., Kim, H., Hwang, J. H., Park, S. Y., Ko, Y. J., Lee, Y. H., Park, J. H., & Park, S. H. (2026). Evaluation of an Effective Intradermal Foot-and-Mouth Disease Vaccine for Early Protection. Vaccines, 14(3), 263. https://doi.org/10.3390/vaccines14030263
Vancouver
Kim DW, Lee SY, Kim TJ, Kim H, Hwang JH, Park SY, et al. Evaluation of an Effective Intradermal Foot-and-Mouth Disease Vaccine for Early Protection. Vaccines. 2026;14(3):263. doi:10.3390/vaccines14030263
BibTeX
@article{Kim2026,
author = {Kim, Dong-Wan and Lee, Seo-Yong and Kim, Tae-Jun and Kim, Hyejin and Hwang, Ji-Hyeon and Park, Sun Young and Ko, Young-Joon and Lee, Yoon-Hee and Park, Jong-Hyeon and Park, Sung-Han},
title = {Evaluation of an Effective Intradermal Foot-and-Mouth Disease Vaccine for Early Protection},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {3},
pages = {263},
doi = {10.3390/vaccines14030263}
}
EUVIMED